Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 11 (November)

1. TANGO is a tumor suppressor of malignant melanoma.
   Int J Cancer, 119(12): 2812-20. [Abstract] [Full-text]
2. Severe pulmonary metastasis in obese and diabetic mice.
   Int J Cancer, 119(12): 2760-7. [Abstract] [Full-text]
3. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
   Int J Cancer, 119(12): 2861-9. [Abstract] [Full-text]
4. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
   Oncogene, 25(52): 6968-74. [Abstract] [Full-text]
5. Associations between ocular melanoma and other primary cancers: an international population-based study.
   Int J Cancer, 120(1): 152-9. [Abstract] [Full-text]
6. The relationship between telomerase activity and proliferation in cutaneous melanoma.
   Med Hypotheses, 68(1): 125-7. [Abstract] [Full-text]
7. Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma.
   J Invest Dermatol, 126(12): 2658-63. [Abstract] [Full-text]
8. Patterns of regional head and neck lymph node metastasis in primary conjunctival malignant melanoma.
   Br J Ophthalmol, 90(12): 1468-71. [Abstract] [Full-text]
9. Malignant melanoma in marathon runners.
   Arch Dermatol, 142(11): 1471-4. [Abstract] [Full-text]
10. The relationship between melanoma thickness and time to diagnosis in a large population-based study.
    Arch Dermatol, 142(11): 1422-7. [Abstract] [Full-text]
11. Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy.
    Cancer Immunol Immunother, 56(1): 88-94. [Abstract] [Full-text]
12. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
    Cancer Immunol Immunother, 56(1): 95-100. [Abstract] [Full-text]
13. Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.
    Cancer Immunol Immunother, 56(1): 101-9. [Abstract] [Full-text]
14. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Cancer, 107(11): 2647-52. [Abstract] [Full-text]
15. Incidence, mortality and survival in cutaneous melanoma.
    J Plast Reconstr Aesthet Surg, 60(1): 32-40. [Abstract] [Full-text]
16. Melanoma of thumb: retrospective study for amputation levels, surgical margin and reconstruction.
    J Plast Reconstr Aesthet Surg, 60(1): 24-31. [Abstract] [Full-text]
17. Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen.
    Cancer Immunol Immunother, 56(2): 165-80. [Abstract] [Full-text]
18. Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.
    Cancer Immunol Immunother, 56(2): 259-69. [Abstract] [Full-text]
19. Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells.
    Cancer Immunol Immunother, 56(2): 193-204. [Abstract] [Full-text]
20. Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.
    Cancer Immunol Immunother, 56(2): 249-58. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.